General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
7 Stocks to Sell as Banks Melt Down | investorplace.com • |
Nabriva (NBRV) Posts Positive Data From Cystic Fibrosis Study | zacks.com • |
Nabriva's stock is up after sharing antibiotic news | marketwatch.com • |
Nabriva Therapeutics plc (NBRV) Q3 2022 Earnings Call Transcript | seekingalpha.com • |
Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022 | globenewswire.com • |
What Is Going on With Nabriva Therapeutics (NBRV) Stock Today? | investorplace.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-08-02 | 2023-06 | 0 | N/A | N/A | N/A |
2023-05-22 | 2023-03 | 0 | N/A | N/A | N/A |
2023-04-17 | 2022-12 | 0 | N/A | N/A | N/A |
2022-11-10 | 2022-09 | -4.03 | N/A | N/A | N/A |
2022-08-03 | 2022-06 | -5 | N/A | N/A | N/A |
2022-05-05 | 2022-03 | -4.75 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2020-12-07 | Morgan Stanley | Upgrade | Equal-Weight | |
2020-04-09 | H.C. Wainwright | Downgrade | Buy | Neutral |
2020-04-09 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2020-04-08 | Needham | Downgrade | Buy | Hold |
2020-03-19 | Wedbush | Downgrade | Outperform | Neutral |
2020-03-17 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-01 | BROOM COLIN | Director | 36.52K | Sale |
2022-08-01 | BURGESS DANIEL D | Director | 10.38K | Sale |
2022-08-01 | CORRIGAN MARK | Director | 7.20K | Sale |
2022-08-10 | DOLAN DANIEL | Chief Financial Officer | 0.00 | Conversion of Exercise of derivative security |
2022-08-10 | GELONE STEVEN P | President | 0.00 | Conversion of Exercise of derivative security |
2022-08-10 | GUICO-PABIA CHRISTINE J | Officer | 0.00 | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-03-30 | Values First Advisors, Inc. | 26.68K | 41.36K | 0.83% |
2023-03-30 | Renaissance Technologies, LLC | 23.36K | 36.21K | 0.73% |
2023-03-30 | Frazier Life Sciences Management, L.P. | 17.02K | 26.39K | 0.53% |
2023-03-30 | Citadel Advisors Llc | 11.61K | 17.99K | 0.36% |
2023-03-30 | Morgan Stanley | 4.11K | 6.37K | 0.13% |
2023-03-30 | Advisor Group Holdings, Inc. | 2.01K | 3.11K | 0.06% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-02-27 | Fidelity NASDAQ Composite Index Fund | 1.71K | 2.65K | 0.05% |
Split | Date |
---|---|
1 : 25 | 2022-09-16 |
1 : 10 | 2020-12-03 |
10 : 1 | 2017-06-26 |
Criminals
F…Ck ur mother bitch , will rise u ll c
Strong bullish to the moon 2500%
Once u bid they get the price down it seems a scam no volume at all
再有几天就要收到纳斯达克的退市警告了
垃圾公司,狗屎一样
这公司财务是不是有问题,怎么和中国的教育股一样
$NBRV Is there a major business problem in this company? Why is it the same price as China's teaching and training stocks
Is there a major business problem in this company? Why is it the same price as China's teaching and training stocks
Is there a major business problem in this company? Why is it the same price as China's teaching and training stocks
Is there a major business problem in this company? Why is it the same price as China's teaching and training stocks